about
Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferonSequence-Specific Fidelity Alterations Associated with West Nile Virus Attenuation in MosquitoesLa Crosse and other forms of California encephalitis.Neuroprotection and reduced proliferation of microglia in ribavirin-treated bornavirus-infected rats.Mechanisms of action of ribavirin in antiviral therapies.Tensaw virus genome sequence and its relation to other Bunyaviridae.Hepatitis C virus therapies: current treatments, targets and future perspectives.Arboviral encephalitides: transmission, emergence, and pathogenesis.In search of a small-molecule inhibitor for respiratory syncytial virus.Antiviral therapy: current concepts and practicesEncephalitic Arboviruses: Emergence, Clinical Presentation, and Neuropathogenesis.Mechanism of action of ribavirin in the treatment of chronic hepatitis C.Ribavirin causes error catastrophe during Hantaan virus replication.Periodic lateralized epileptiform discharges in La Crosse encephalitis, a worrisome subgroup: clinical presentation, electroencephalogram (EEG) patterns, and long-term neurologic outcome.Inhibitory effect of a nucleotide analog on infectious salmon anemia virus infection.Identification of a ribavirin-resistant NS5B mutation of hepatitis C virus during ribavirin monotherapy.
P2860
Q28344042-A27959E7-49EC-4B0A-B54C-497338BB8B27Q28545853-FAE0F93F-E35A-43D4-9EF8-0A236564952CQ33534656-5C49BBB2-DB75-4383-AD92-5E7242045283Q34109709-33E5295B-88B1-4449-914D-9FE0A928111BQ34521747-1CAEC970-9A2B-4AA7-925A-0E16753E40DBQ35003493-6F4EDE15-A47B-4B44-A7D4-49CB4850BEA5Q35147050-2DA91B9C-9217-467F-BFD8-21127EBCFC3DQ35778817-D8D7B664-92F3-4BFE-8BF4-06501EB18B5BQ35917503-85D89607-14CE-4468-8726-4A570F6E7E22Q36070394-3DED43D8-1836-4A25-AAFF-209D9082F6D3Q37136479-2B3CF3F2-EFFB-44CB-B1A1-396C4C03878DQ37940977-8EFA1020-84F5-4042-803C-6FB532A9E399Q39698441-0CFF83E8-8D1A-4B40-A018-E034DE0F221FQ40431057-0FA56E5F-0AAB-45F8-AD2C-8DB502354240Q42113871-6B4D3F58-E1CA-432E-9437-601165C02BF4Q42980354-B92D9B0A-B0FC-4DA7-8660-332105EC81E7
P2860
description
1989 nî lūn-bûn
@nan
1989 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Mechanism of La Crosse virus inhibition by ribavirin.
@ast
Mechanism of La Crosse virus inhibition by ribavirin.
@en
type
label
Mechanism of La Crosse virus inhibition by ribavirin.
@ast
Mechanism of La Crosse virus inhibition by ribavirin.
@en
prefLabel
Mechanism of La Crosse virus inhibition by ribavirin.
@ast
Mechanism of La Crosse virus inhibition by ribavirin.
@en
P2860
P356
P1476
Mechanism of La Crosse virus inhibition by ribavirin.
@en
P2093
Cassidy LF
Patterson JL
P2860
P304
P356
10.1128/AAC.33.11.2009
P407
P577
1989-11-01T00:00:00Z